U.S. Court of Appeals for the Federal Circuit, 2024

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.
U.S. Court of Appeals for the Federal Circuit · Decided September 4, 2024

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.

Opinion

Case: 24-1829 Document: 31 Page: 1 Filed: 09/04/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ ALEXION PHARMACEUTICALS, INC., ALEXION PHARMA INTERNATIONAL OPERATIONS LTD., Plaintiffs-Appellants v. SAMSUNG BIOEPIS CO. LTD., Defendant-Appellee ______________________ 2024-1829 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:24-cv-00005-GBW, Judge Gregory Brian Williams. ______________________ ORDER The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 24-1829 Document: 31 Page: 2 Filed: 09/04/2024

2 ALEXION PHARMACEUTICALS, INC. V. SAMSUNG BIOEPIS CO. LTD.

(2) Each side shall bear their own costs.

FOR THE COURT

September 4, 2024 Date

ISSUED AS A MANDATE: September 4, 2024

Case-law data current through December 31, 2025. Source: CourtListener bulk data.